Somatostatin type-2 receptor activation inhibits glutamate release and prevents status epilepticus

Neurobiology of Disease

Volumn 54, Issue , 2013, Pages 94-104

  Kozhemyakin, Maxim ^a   Rajasekaran, Karthik ^a   Todorovic, Marko S ^a   Kowalski, Samuel L ^a   Balint, Corinne ^a   Kapur, Jaideep ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Glutamate; Somatostatin; Somatostatin type 2 receptors; Status epilepticus; Synaptic transmission

Indexed keywords

ANGIOPEPTIN; CYANAMIDE; GLUTAMIC ACID; OCTREOTIDE; PILOCARPINE; SOMATOSTATIN; SOMATOSTATIN RECEPTOR 2;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; EPILEPTIC STATE; EXCITATORY POSTSYNAPTIC POTENTIAL; FACILITATION; HIPPOCAMPAL CA1 REGION; MALE; NEUROMODULATION; NEUROTRANSMITTER RELEASE; NONHUMAN; PAIRED PULSE FACILITATION; PATCH CLAMP; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; SYNAPTIC TRANSMISSION;

ANIMALS; CA1 REGION, HIPPOCAMPAL; EXCITATORY POSTSYNAPTIC POTENTIALS; GLUTAMIC ACID; MALE; PATCH-CLAMP TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN; STATUS EPILEPTICUS; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 84875598250     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2013.02.015     Document Type: Article

References (66)

1. Aourz N., De Bundel D., Stragier B., Clinckers R., Portelli J., Michotte Y., Smolders I. Rat hippocampal somatostatin SST3 and SST4 receptors mediate anticonvulsive effects in vivo: indications of functional interactions with SST2 receptors. Neuropharmacology 2011, 61:1327-1333.
2. Banks W.A. The CNS as a target for peptide and peptide-based drugs. Expert Opin. Drug Deliv. 2006, 3:707-712.
3. Banks W.A., Schally A.V., Barrera C.M., Fasold M.B., Durham D.A., Csernus V.J., Groot K., Kastin A.J. Permeability of the murine blood-brain barrier to some octapeptide analogs of somatostatin. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:6762-6766.
4. Bean B.P. Neurotransmitter inhibition of neuronal calcium currents by changes in channel voltage dependence. Nature 1989, 340:153-156.
5. Beaumont V., Hepworth M.B., Luty J.S., Kelly E., Henderson G. Somatostatin receptor desensitization in NG108-15 cells. A consequence of receptor sequestration. J. Biol. Chem. 1998, 273:33174-33183.
6. Boehm S., Betz H. Somatostatin inhibits excitatory transmission at rat hippocampal synapses via presynaptic receptors. J. Neurosci. 1997, 17:4066-4075.
7. Borris D.J., Bertram E.H., Kapur J. Ketamine controls prolonged status epilepticus. Epilepsy Res. 2000, 42:117-122.
8. 2A receptor expression and cell surface availability in central neurons: role of receptor internalization. J. Neurosci. 2000, 20:5932-5939.
9. Cabezas C., Buno W. Distinct transmitter release properties determine differences in short-term plasticity at functional and silent synapses. J. Neurophysiol. 2006, 95:3024-3034.
10. Cammalleri M., Cervia D., Langenegger D., Liu Y., Dal Monte M., Hoyer D., Bagnoli P. Somatostatin receptors differentially affect spontaneous epileptiform activity in mouse hippocampal slices. Eur. J. Neurosci. 2004, 20:2711-2721.
11. Dolphin A.C. G protein modulation of voltage-gated calcium channels. Pharmacol. Rev. 2003, 55:607-627.
12. 2A in rat brain using a specific anti-peptide antibody. J. Neurosci. 1996, 16:4468-4478.
13. 2A receptors and somatostatin-containing axons in rat brain: evidence for regulation of cell surface receptors by endogenous somatostatin. J. Neurosci. 1998, 18:1056-1071.
14. Emptage N.J., Reid C.A., Fine A. Calcium stores in hippocampal synaptic boutons mediate short-term plasticity, store-operated Ca2+ entry, and spontaneous transmitter release. Neuron 2001, 29:197-208.
15. Fricker G., Nobmann S., Miller D.S. Permeability of porcine blood brain barrier to somatostatin analogues. Br. J. Pharmacol. 2002, 135:1308-1314.
16. Fritsch B., Stott J.J., Joelle D.J., Rogawski M.A. Treatment of early and late kainic acid-induced status epilepticus with the noncompetitive AMPA receptor antagonist GYKI 52466. Epilepsia 2010, 51:108-117.
17. A receptors. J. Neurosci. 2005, 25:5511-5520.
18. A receptors during status epilepticus. J. Neurosci. 2008, 28:2527-2538.
19. Grilli M., Raiteri L., Pittaluga A. Somatostatin inhibits glutamate release from mouse cerebrocortical nerve endings through presynaptic SST2 receptors linked to the adenylyl cyclase-protein kinase A pathway. Neuropharmacology 2004, 46:388-396.
20. Hannon J.P., Petrucci C., Fehlmann D., Viollet C., Epelbaum J., Hoyer D. Somatostatin SST2 receptor knock-out mice: localisation of SST1-5 receptor mRNA and binding in mouse brain by semi-quantitative RT-PCR, in situ hybridisation histochemistry and receptor autoradiography. Neuropharmacology 2002, 42:396-413.
21. Hicks G.A., Feniuk W., Humphrey P.P.A. Outward current produced by somatostatin (SIRF) in rat anterior cingulated pyramidal cells in vitro. Br. J. Pharmacol. 1998, 124:252-258.
22. 2A somatostatin receptor. J. Biol. Chem. 1997, 272:13869-13876.
23. Hoyer D., Bell G.I., Berelowitz M., Epelbaum J., Feniuk W., Humphrey P.P., O'Carroll A.M., Patel Y.C., Schonbrunn A., Taylor J.E. Classification and nomenclature of somatostatin receptors. Trends Pharmacol. Sci. 1995, 16:86-88.
24. Ikeda S.R., Dunlap K. Voltage-dependent modulation of N-type calcium channels: role of G protein subunits. Adv. Second Messenger Phosphoprotein Res. 1999, 33:131-151.
25. A receptors. J. Neurosci. 1997, 17:7532-7540.
26. Koenig J.A., Edwardson J.M., Humphrey P.P. Somatostatin receptors in Neuro2A neuroblastoma cells: ligand internalization. Br. J. Pharmacol. 1997, 120:52-59.
27. Kozhemyakin M., Rajasekaran K., Kapur J. Central cholinesterase inhibition enhances glutamatergic synaptic transmission. J. Neurophysiol. 2010, 103:1748-1757.
28. Liu Q., Cescato R., Dewi D.A., Rivier J., Reubi J.C., Schonbrunn A. Receptor signaling and endocytosis are differentially regulated by somatostatin analogs. Mol. Pharmacol. 2005, 68:90-101.
29. Lothman E.W., Bertram E.H., Bekenstein J.W., Perlin J.B. Self-sustaining limbic status epilepticus induced by 'continuous' hippocampal stimulation: electrographic and behavioral characteristics. Epilepsy Res. 1989, 3:107-119.
30. Marchi N., Oby E., Batra A., Uva L., De Curtis M., Hernandez N., Boxel-Dezaire A., Najm I., Janigro D. In vivo and in vitro effects of pilocarpine: relevance to ictogenesis. Epilepsia 2007, 48:1934-1946.
31. Marchi N., Fan Q., Ghosh C., Fazio V., Bertolini F., Betto G., Batra A., Carlton E., Najm I., Granata T., Janigro D. Antagonism of peripheral inflammation reduces the severity of status epilepticus. Neurobiol. Dis. 2009, 33:171-181.
32. Martin B.S., Kapur J. A combination of ketamine and diazepam synergistically controls refractory status epilepticus induced by cholinergic stimulation. Epilepsia 2008, 49:248-255.
33. Mazarati A.M., Telegdy G. Effects of somatostatin and anti-somatostatin serum on picrotoxin-kindled seizures. Neuropharmacology 1992, 31:793-797.
34. Mazarati A., Wasterlain C.G. Anticonvulsant effects of four neuropeptides in the rat hippocampus during self-sustaining status epilepticus. Neurosci. Lett. 2002, 331:123-127.
35. McDonough J.H., Shih T.M. Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology. Neurosci. Biobehav. Rev. 1997, 21:559-579.
36. Meierkord H., Boon P., Engelsen B., Gocke K., Shorvon S., Tinuper P., Holtkamp M. EFNS guideline on the management of status epilepticus in adults. Eur. J. Neurol. 2010, 17:348-355.
37. Mirotznik R.R., Zheng X., Stanley E.F. G-Protein types involved in calcium channel inhibition at a presynaptic nerve terminal. J. Neurosci. 2000, 20:7614-7621.
38. Moneta D., Richichi C., Aliprandi M., Dournaud P., Dutar P., Billard J.M., Carlo A.S., Viollet C., Hannon J.P., Fehlmann D., Nunn C., Hoyer D., Epelbaum J., Vezzani A. Somatostatin receptor subtypes 2 and 4 affect seizure susceptibility and hippocampal excitatory neurotransmission in mice. Eur. J. Neurosci. 2002, 16:843-849.
39. Monno A., Rizzi M., Samanin R., Vezzani A. Anti-somatostatin antibody enhances the rate of hippocampal kindling in rats. Brain Res. 1993, 602:148-152.
40. Moore S.D., Madamba S.G., Joels M., Siggins G.R. Somatostatin augments the M-current in hippocampal neurons. Science 1988, 239:278-280.
41. A receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus. J. Neurosci. 2005, 25:7724-7733.
42. Neligan A., Shorvon S.D. Frequency and prognosis of convulsive status epilepticus of different causes: a systematic review. Arch. Neurol. 2010, 67:931-940.
43. Okumura T., Takasu N., Ishimatsu S., Miyanoki S., Mitsuhashi A., Kumada K., Tanaka K., Hinohara S. Report on 640 victims of the Tokyo subway sarin attack. Ann. Emerg. Med. 1996, 28:129-135.
44. Olivos L., Artalejo A.R. Muscarinic excitation-secretion coupling in chromaffin cells. Acta Physiol (Oxf.) 2008, 192:213-220.
45. Perez J., Rigo M., Kaupmann K., Bruns C., Yasuda K., Bell G.I., Lubbert H., Hoyer D. Localization of somatostatin (SRIF) SSTR-1, SSTR-2 and SSTR-3 receptor mRNA in rat brain by in situ hybridization. Naunyn Schmiedebergs Arch. Pharmacol. 1994, 349:145-160.
46. Piwko C., Thoss V.S., Probst A., Hoyer D. The elusive nature of cerebellar somatostatin receptors: studies in rat, monkey and human cerebellum. J. Recept. Signal Transduct. Res. 1997, 17:385-405.
47. Qiu C., Zeyda T., Johnson B., Hochgeschwender U., de Lecea L., Tallent M.K. Somatostatin receptor subtype 4 couples to the M-current to regulate seizures. J. Neurosci. 2008, 28:3567-3576.
48. Racine R.J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 1972, 32:281-294.
49. Rajasekaran K., Kapur J., Bertram E.H. Alterations in GABA(A) receptor mediated inhibition in adjacent dorsal midline thalamic nuclei in a rat model of chronic limbic epilepsy. J. Neurophysiol. 2007, 98:2501-2508.
50. Rajasekaran K., Sun C., Bertram E.H. Altered pharmacology and GABA-A receptor subunit expression in dorsal midline thalamic neurons in limbic epilepsy. Neurobiol. Dis. 2009, 33:119-132.
51. Rajasekaran K., Todorovic M., Kapur J. Calcium-permeable AMPA receptors are expressed in a rodent model of status epilepticus. Ann. Neurol. 2012, 72:91-102.
52. Robertson C.R., Flynn S.P., White H.S., Bulaj G. Anticonvulsant neuropeptides as drug leads for neurological diseases. Nat. Prod. Rep. 2011, 28:741-762.
53. Schulz S., Handel M., Schreff M., Schmidt H., Hollt V. Localization of five somatostatin receptors in the rat central nervous system using subtype-specific antibodies. J. Physiol. Paris 2000, 94:259-264.
54. Stevens C.F., Wang Y. Changes in the reliability of synaptic function as a mechanism for plasticity. Nature 1994, 371:704-707.
55. Stragier B., Clinckers R., Meurs A., De Bundel D., Sarre S., Ebinger G., Michotte Y., Smolders I. Involvement of the somatostatin-2 receptor in the anti-convulsant effect of angiotensin IV against pilocarpine-induced limbic seizures in rats. J. Neurochem. 2006, 98:1100-1113.
56. Sun J., Kapur J. M-type potassium channels modulate Schaffer-collateral CA1 glutamatergic synaptic transmission. J. Physiol. 2012, 590:3953-3964.
57. Tallent M.K., Siggins G.R. Somatostatin depresses excitatory but not inhibitory neurotransmission in rat CA1 hippocampus. J. Neurophysiol. 1997, 78:3008-3018.
58. Tallent M.K., Siggins G.R. Somatostatin acts in CA1 and CA3 to reduce hippocampal epileptiform activity. J. Neurophysiol. 1999, 81:1626-1635.
59. Todorovic M.S., Cowan M.L., Balint C.A., Sun C., Kapur J. Characterization of status epilepticus induced by two organophosphates in rats. Epilepsy Res. 2012, 101:268-276.
60. Treiman D.M., Walton N.Y., Kendrick C. A progressive sequence of electroencephalographic changes during generalized convulsive status epilepticus. Epilepsy Res. 1990, 5:49-60.
61. Treiman D.M., Meyers P.D., Walton N.Y., Collins J.F., Colling C., Rowan A.J., Handforth A., Faught E., Calabrese V.P., Uthman B.M., Ramsay R.E., Mamdani M.B. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N. Engl. J. Med. 1998, 339:792-798.
62. Turski L., Ikonomidou C., Turski W.A., Bortolotto Z.A., Cavalheiro E.A. The seizures induced by pilocarpine: a novel experimental model of intractable epilepsy. Synapse 1989, 3:154-171.
63. Uva L., Librizzi L., Marchi N., Noe F., Bongiovanni R., Vezzani A., Janigro D., De Curtis M. Acute induction of epileptiform discharges by pilocarpine in the in vitro isolated guinea-pig brain requires enhancement of blood-brain barrier permeability. Neuroscience 2008, 151:303-312.
64. Vezzani A., Serafini R., Stasi M.A., Vigano G., Rizzi M., Samanin R. A peptidase-resistant cyclic octapeptide analogue of somatostatin (SMS 201-995) modulates seizures induced by quinolinic and kainic acids differently in the rat hippocampus. Neuropharmacology 1991, 30:345-352.
65. Wang N.C., Good L.B., Marsh S.T., Treiman D.M. EEG stages predict treatment response in experimental status epilepticus. Epilepsia 2009, 50:949-952.
66. Zafar R., King M.A., Carney P.R. Adeno-associated viral vector-mediated expression of somatostatin in rat hippocampus suppresses seizure development. Neurosci. Lett. 2012, 509:87-91.